Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_370ca28a580f6b11f2ed9bd04a153e55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
filingDate |
2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1587ba0b30845cac61e72d42cf4a507c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aad0367390af4111dd52675d232791c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30635012eb7d206404c1ff6a3bd5737c |
publicationDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011231053-A |
titleOfInvention |
APOBEC3 expression enhancer and anti-HIV agent |
abstract |
An object of the present invention is to provide an APOBEC3 expression enhancer containing, as an active ingredient, a compound that improves the expression of APOBEC3, which is a host factor having an anti-HIV-1 action. Another object of the present invention is to provide an anti-HIV agent containing the above compound as an active ingredient. An APOBEC3 expression enhancer and an anti-HIV agent comprising a disulfide compound as defined herein as an active ingredient. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018174097-A1 |
priorityDate |
2010-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |